Net revenue grew 3.7% in 2024, with strong Q4 sales but lower annual adjusted EBITDA and net income due to margin pressures and higher costs. The chemical segment outperformed, while steel faced pricing headwinds. Strategic investments and a share buyback program were key highlights.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.